ROCHE PRODUCTS PTY LTD

ABN: 70000132865Sydney, NSW
Enterprise ($50M+)
$670.9M
Total Value
2
Total Contracts
Drugs and Pharmaceutical
Primary Category

Recent Contracts

Active
Drugs and Pharmaceutical
18 July 2025
CN4171505—Procurement of Imported Plasma and Recombinant Products (IPRP) – Hemlibra (emicizumab)$317.7M

30 June 2025 - 29 June 2028

National Blood Authority
Expired
Drugs and Pharmaceutical
4 Nov 2020
CN3727716—Supply of Hemlibra$353.2M

31 Oct 2020 - 29 June 2025

National Blood Authority

Retender Opportunities

10 retender opportunities found

Expiring contracts in your categories that may be retendered soon.

Peer Benchmarking

See how ROCHE PRODUCTS PTY LTD ranks against similar companies in their category and size band.

Financial Year Breakdown

FY25
$317.7M(1 contracts)
FY21
$353.2M(1 contracts)

Company Details

Name
ROCHE PRODUCTS PTY LTD
Also known as
Roche Foundation Medicine
Entity Type
Australian Private Company
ABN
70 000 132 865
Town/City
Sydney
Postcode
2000
State/Territory
NSW
Country
Australia

Similar Suppliers

GLAXOSMITHKLINE AUSTRALIA PTY LTD$1.5BPFIZER AUSTRALIA PTY LTD$760.2MSEQIRUS (AUSTRALIA) PTY LTD$1.8BSANOFI-AVENTIS AUSTRALIA PTY LTD$538.1MCSL BEHRING (AUSTRALIA) PTY LTD$2.2B